MeSH term
Frequency | Condition_Probility | Humans | 22 | 0.0 |
Blotting, Western | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Cyclic AMP/metabolism | 3 | 0.0 |
Phosphodiesterase Inhibitors/*pharmacology | 2 | 4.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Phosphodiesterase Inhibitors/pharmacology | 2 | 1.0 |
Xanthines/pharmacology | 2 | 12.0 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/*genetics | 4 | 40.0 |
Comparative Study | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Gene Frequency | 3 | 0.0 |
Japan | 3 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Animals | 8 | 0.0 |
Base Sequence | 5 | 0.0 |
COS Cells | 2 | 0.0 |
Mice | 2 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Transfection | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/*antagonists & inhibitors | 2 | 13.0 |
Clone Cells | 2 | 0.0 |
Rats | 2 | 0.0 |
Cyclic AMP/physiology | 2 | 1.0 |
Male | 3 | 0.0 |
Catalytic Domain | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Adult | 2 | 0.0 |
Diabetes Mellitus, Type 2/*genetics | 2 | 1.0 |
Female | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
